Efficacy of 0.01% Atropine Ophthalmic Solution on Myopia Progression and Axial Elongation of the Eye in School Children with High- or Moderate-grade Myopia - Efficacy of 0.01% Atropine Ophthalmic Solution on Myopia Progression and Axial Elongation of the Eye in School Children with High- or Moderate-grade Myopia

Kawasaki Medical School Department of Ophthalmology 20 个研究点目标入组 50 人开始时间: 2017年9月15日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Children with abnormal binocular function (2) Children with amblyopia or manifest strabismus (3) Children with ocular disorders other than myopia (4) Children with ocular or systemic disorders that potentially affect myopia or refractive power (5) Children who have received previous treatment for myopia control that included atropine therapy, bifocal lenses, progressive lenses, and Ortho-K. (6) Children with a history of cardiovascular or respiratory disease (7) Children who have received pharmacotherapy for asthma in the past year (8) Children with allergy to atropine, cyclopentolate, or benzalkonium (9) Children who cannot use eye drops (10) Children who plans to use contact lenses during the follow-up period

发起方

Kawasaki Medical School Department of Ophthalmology 2